Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023

BUY
$26.9 - $30.58 $28,110 - $31,956
1,045 Added 12.67%
9,296 $262,000
Q3 2022

Nov 09, 2022

SELL
$29.42 - $42.25 $1,794 - $2,577
-61 Reduced 0.73%
8,251 $248,000
Q2 2022

Aug 12, 2022

SELL
$30.15 - $45.79 $2,200 - $3,342
-73 Reduced 0.87%
8,312 $282,000
Q1 2022

Apr 29, 2022

BUY
$36.01 - $53.14 $4,429 - $6,536
123 Added 1.49%
8,385 $376,000
Q4 2021

Feb 14, 2022

BUY
$32.35 - $48.27 $267,275 - $398,806
8,262 New
8,262 $382,000
Q2 2020

Aug 12, 2020

SELL
$18.68 - $24.35 $388,544 - $506,480
-20,800 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$21.11 - $25.92 $159,000 - $195,229
-7,532 Reduced 26.58%
20,800 $486,000
Q3 2019

Oct 16, 2019

SELL
$18.06 - $24.1 $1.87 Million - $2.49 Million
-103,395 Reduced 78.49%
28,332 $596,000
Q2 2019

Jul 17, 2019

BUY
$19.6 - $29.31 $162,464 - $242,950
8,289 Added 6.72%
131,727 $2.69 Million
Q1 2019

May 15, 2019

BUY
$23.58 - $28.43 $158,622 - $191,248
6,727 Added 5.76%
123,438 $3.47 Million
Q4 2018

Jan 15, 2019

BUY
$20.63 - $34.04 $477,110 - $787,243
23,127 Added 24.71%
116,711 $2.86 Million
Q3 2018

Nov 14, 2018

BUY
$20.6 - $37.15 $1.93 Million - $3.48 Million
93,584 New
93,584 $3.48 Million

Others Institutions Holding IRMD

About IRADIMED CORP


  • Ticker IRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,565,100
  • Market Cap $679M
  • Description
  • IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...
More about IRMD
Track This Portfolio

Track Navellier & Associates Inc Portfolio

Follow Navellier & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Navellier & Associates Inc with notifications on news.